Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration

Alexander Lin1,2, Niridu Jude Peiris1,3, Harkirat Dhaliwal1,3

  • 1Heart Research Institute, Sydney, NSW 2042, Australia.

Cells
|April 3, 2021
PubMed

Insights

Mural cell dysfunction contributes to cardiovascular and neurodegenerative diseases. Targeting conserved signaling pathways offers a dual therapeutic approach for both conditions.

Area of Science:

  • Vascular Biology
  • Neurodegenerative Diseases
  • Cardiovascular Research

Background:

  • Mural cells (smooth muscle cells and pericytes) are vital for vascular health, regulating blood pressure and vessel integrity.
  • Mural cell dysfunction is implicated in atherosclerosis and increasingly recognized in neurodegenerative diseases like Alzheimer's and Parkinson's.

Purpose of the Study:

  • To review mechanisms of atherosclerosis and neurodegeneration, focusing on mural cell plasticity.
  • To identify conserved signaling pathways (PDGF, Notch, inflammatory) in both disease types.
  • To propose dual-acting therapeutics targeting these conserved pathways.

Main Methods:

  • Literature review of mural cell function in cardiovascular and neurodegenerative diseases.
  • Analysis of conserved signaling pathways implicated in mural cell plasticity.
  • Exploration of therapeutic strategies targeting shared molecular mechanisms.

Main Results:

  • Mural cell plasticity is a key mechanism in both atherosclerosis and neurodegeneration.
  • Specific signaling pathways, including PDGF, Notch, and inflammatory signaling, are conserved across these conditions.
  • These conserved pathways represent potential targets for novel therapeutic interventions.

Conclusions:

  • Dysfunctional mural cells contribute to both cardiovascular and neurodegenerative pathologies.
  • Targeting conserved mural cell signaling pathways may lead to dual-acting therapies.
  • Developing therapeutics with cardio- and neuroprotective qualities is a promising avenue for future research.